Distribution, tolerability and tissue compatibility of intrathecal tizanidine in the sheep

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 7, 1998, Pages 786-793

  Ochs, G ^a,b   Loew, M ^a   Tonn, J ^a   Toyka, K ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Alpha 2 adrenergic; Intrathecal application; Pharmacokinetics; Tizanidine; Toxicity

Indexed keywords

TIZANIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHRONIC PAIN; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOXICITY; INTRATHECAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; SPINAL CORD;

EID: 0031850268     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05323.x     Document Type: Article

References (40)

1. Amer S, Rawal N, Gustafsson LL. Clinical experience of long-term treatment with epidural and intrathecal opioids -a nationwide survey. Acta Anaesthesiol Scand 1988: 32: 253-259.
2. Brown DV, McCarthy RJ. Epidural and spinal opioids. Curr Opin Anaesthesiol 1995: 8: 337-341.
3. Castro MJ, Eisenach JC. Pharmacokinetics and -dynamics of intravenous, intrathecal, and epidural clonidine in sheep. Anesthesiology 1989: 71: 418-425.
4. Coombs DW, Colburn RW, Allen CD et al. Toxicity of chronic spinal analgesia in a canine model: neuropathologic observations with dezocine lactate. Reg Anaesth 1990: 15: 94-102.
5. Coombs DW, Saunders R, Gaylor M et al. Clinical trial of intrathecal clonidine for cancer pain. J Reg Anesth 1984: 9: 34-35.
6. Coombs DW, Saunders RL, LaChance D et al. Intrathecal morphine tolerance: Use of intrathecal clonidine, DADLE, and intraventricular morphine. Anesthesiology 1985: 62: 358-363.
7. Eisenach JC, Dewan DM, Rose JC et al. Epidural clonidine produces antinociception, but not hypotension in sheep. Anesthesiology 1987: 66: 496-501.
8. Eisenach JC, DuPen S, Dubois M et al. Epidural clonidine analgesia for intractable cancer pain. Pain 1995: 61: 391-399.
9. Eisenach JC, Grice SC. Epidural clonidine does not decrease blood pressure or spinal cord blood flow in awake sheep. Anesthesiology 1988: 68: 335-340.
10. Eisenach JC, Tong C. Site of hemodynamic effects of intrathecal alpha-2-adrenergic agonists. Anesthesiology 1991: 74: 766-771.
11. Emre M, Leslie GC, Muir C et al. Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud registered). J Neurol Neurosurg Psychiatry 1994: 57: 1355-1359.
12. Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: A placebo-controlled double-blind cross-over study. Headache 1992: 32: 509-513.
13. Follett KA, Hitchon PW, Piper J et al. Response of intractable pain to continuous intrathecal morphine: a retrospective study. Pain 1992: 49: 21-25.
14. Fromm GH, Aumentado D, Terrence CF. A clinical and experimental investigation of the effects of tizanidine in trigeminal neuralgia. Pain 1993: 53: 265-271.
15. Gaumann DM, Yaksh TL. Intrathecal somatostatin in rats: antinociception only in the presence of toxic effects. Anesthesiology 1988: 68: 733-742.
16. Ishizuki M, Yanagisawa M. Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rats. Pain 1992: 48: 101-106.
17. Klockgether T, Schwarz M, Wullner U et al. Myorelaxant effect after intrathecal injection of antispastic drugs in rats. Neurosci Lett 1989: 97: 221-226.
18. Kotab HIM, Hand CW, Moore RA et al. Intrathecal morphine and heroin in humans: six-hour drug levels in spinal fluid and plasma. Anesth Analg 1986: 65: 718-722.
19. Krames ES. Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993: 8: 36-46.
20. Kroin JS, McCarthy RJ, Penn RD et al. Intrathecal clonidine and tizanidine in conscious dogs: comparison of analgesia and hemodynamics. Anesth Analg 1996: 82: 627-635.
21. Kroin JS, Penn RD. Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Rutgers AWF (eds). Parenteral Drug Therapy in Spasticity and Parkinson's Disease. Lancs, UK: Parthenon, 1992: 67-78.
22. Leiphart JW, Dills CV, Zikel OM et al. A comparison of intrathecally administered narcotic and nonnarcotic analgesics for experimental chronic neuropathic pain. J Neurosurg 1995: 82: 595-599.
23. Levy R, Leiphart J, Dills C. Analgesic action of acute and chronic intraspinally administered opiate and alpha-2-adrenergic agonists in chronic neuropathic pain. Stereotact Funct Neurosurg 1994: 62: 279-289.
24. McCarthy RJ, Kroin JS, Lubenow TR et al. Effect of intrathecal tizanidine on antinociception and blood pressure in the rat. Pain 1990: 40: 333-338.
25. Milanov I, Georgiev D. Mechanisms of tizanidine action on spasticity. Acta Neurol Scand 1994: 89: 274-279.
26. Moulin DE, Inturrisi CE, Foley KM. Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala-D-Leu-enkephalin. Ann Neurol 1986: 20: 218-222.
27. Möllenholt P, Post C, Paulsson I et al. Intrathecal and epidural somatostatin in rats: can antinociception, motor effects and neurotoxicity be separated? Pain 1990: 43: 363-370.
28. Nakashima K, Tumura R, Wang Y et al. Effects of tizanidine administration on exteroceptive suppression of the temporalis muscle in patients with chronic tension-type headache. Headache 1994: 34: 455-457.
29. Nordberg G, Hedner T, Mellestrand T et al. Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984: 60: 448-454.
30. Ochs G, Struppler A, Meyerson BA et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry 1989: 52: 933-939.
31. Rawal N, Arner S, Gustafsson LL et al. Present state of extradura] and intrathecal opioid analgesia in Sweden. A nationwide follow-up survey. Br J Anaesth 1987: 59: 791-799.
32. Sakuta M, Takeda K. Beneficial effect of tizanidine on the ischémie muscle contraction in chronic muscle contraction headache. Cephalalgia 1991: 11: 339-340.
33. Sallerin-Caute B, Lazorthes Y, Monsarrat B et al. CSF baclofen levels after intrathecal administration in severe spasticity. Eur J Clin Pharmacol 1991: 40: 363-365.
34. Sjöström S, Tamsen A, Persson MP et al. Pharmacokinetics of intrathecal morphine and meperidine in humans. Anesthesiology 1987: 67: 889-895.
35. Stewart P, Isaac L. Localization of dynorphin-induced neurotoxicity in rat spinal cord. Life Sci 1989: 44: 1505-1514.
36. Vaught JL, Scott R. Species differences in the behavioral toxicity produced by intrathecal substance P antagonists; relationship to analgesia. Life Sci 1987: 40: 175-181.
37. Yaksh TL, Onofrio BM. Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians. Pain 1987: 31: 211-223.
38. Yaksh TL, Pogref JW, Youn Woo Lee et al. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists. J Pharmacol Exp Ther 1995: 272: 207-214.
39. Yaksh TL, Rathbun M, Jage J et al. Pharmacology and toxicology of chronically infused epidural clonidine × HCl in dogs. Fundam Appl Toxicol 1994: 23: 319-335.
40. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983: 16: 109-110.